Satellos Bioscience (MSLE)
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases...
- Open
- 9.695
- High
- 9.695
- Low
- 9.330
- Prev. Close
- 9.790
- Volume
- 16.86K
- Turnover
- 159.06K
- Avg Price
- 9.435
- Bid/Ask Ratio
- --
- Amplitude
- 3.73%
- 52wk High
- 13.395
- Volume Ratio
- 0.16
- Turnover Ratio
- 0.09%
Satellos Bioscience Analyst Rating
View moreForecast & Rating
Sep 10, 2026Price forecast
$26.25180.45%
Forecast & RatingStrong buy
5analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 18 hours ago
Satellos Bioscience to Showcase Forazapadin Program at World Muscle Society Congress
- PUBT · Sep 10 at 09:07 PM
Satellos Bioscience releases investor presentation on Duchenne muscular dystrophy program
- Tip Ranks · Sep 1 at 11:31 AM
Satellos Bioscience to Showcase DMD Drug Program at September Investor Conferences
- PUBT · Sep 1 at 11:00 AM
Satellos Bioscience joins Cantor Global Healthcare Conference investor lineup
- Tip Ranks · Aug 30 at 01:25 PM
LifeSci Capital Sticks to Their Buy Rating for Satellos Bioscience (MSLE)
